Registry of monoclonal gammopathies is currently one of the main Czech Myeloma Group projects. The purpose of this project is the prospective data analysis of monoclonal gammopathies patients in the region of the middle and also the east Europe including incidence of diseases, therapeutic modalities used, the treatment results and the most frequent averse events of therapy.
This ambitious project could lead along better care about these patients in the future.